Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›EXTRANEAL Solution for peritoneal dialysis
Medicines register · Ireland

EXTRANEAL Solution for peritoneal dialysis

Authorisation PA25288/003/001 · Vantive Belgium SRL

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
Vantive Belgium SRL (all products →)
Active substances
Icodextrin, Sodium chloride, Sodium (S) - lactate, Calcium chloride, Magnesium chloride
Clinical trials
3 clinical trials → 22 clinical trials →
Dosage form
Solution for peritoneal dialysis
Route of administration
Intraperitoneal use
ATC code
B05DA
First authorised
25/07/1997
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Not Currently Available

Icodextrin: supply and approvals

2 authorised products on the HPRA list contain Icodextrin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Sodium chloride: supply and approvals

126 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
Sodium Acetate Injection: in shortage, updated 15 Nov 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Sodium (S) - lactate: supply and approvals

3 authorised products on the HPRA list contain Sodium (S) - lactate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 29 years (since 25 July 1997). The HPRA list marks it as marketed in Ireland.

Other medicines with Icodextrin in Ireland

1 other product on the HPRA list contains Icodextrin, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Notecor solution for peritoneal dialysisNoridem Enterprises LimitedNational authorisation (PA)Not marketed

Other medicines with Sodium chloride in Ireland

121 other products on the HPRA list contain Sodium chloride, from 22 licence holders; 76 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
0.9 % w/v Sodium Chloride Injection BPB. Braun Melsungen AGNational authorisation (PA)Marketed
Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Accusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
CLINIMIX N14G30E, solution for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Compound Sodium Lactate Intravenous Infusion BP, Solution for Infusion (Hartmann’s Solution)B. Braun Melsungen AGNational authorisation (PA)Marketed
Compound Sodium Lactate Solution for Infusion BPBaxter Holding B.V.National authorisation (PA)Marketed
Dioralyte Blackcurrant Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Citrus Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Natural, Powder for oral solutionPhoenix LabsNational authorisation (PA)Marketed
Dona 1500 mg Powder for oral solutionCooper Consumer Health B.V.National authorisation (PA)Marketed
Gelaspan Solution for InfusionB. Braun Melsungen AGNational authorisation (PA)Marketed

All 122 products with Sodium chloride →

Other substances in ATC group B05DA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group B05DA with this product:

Calcium chloride dihydrate (1) · Magnesium chloride hexahydrate (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Vantive Belgium SRL holds 27 products on the HPRA list, with 43 different active substances; 14 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.